Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2010
10/14/2010US20100260782 NOVEL ANTI- Alpha 5 Beta 1 ANTIBODIES AND USES THEREOF
10/14/2010US20100260776 Therapeutic method for reducing angiogenesis
10/14/2010US20100260773 Antibody molecules having binding specificity for human il-13
10/14/2010US20100260769 Endosialin binding molecules
10/14/2010US20100260768 Anti mif antibodies
10/14/2010US20100260765 Targeted binding agents directed to kdr and uses thereof - 035
10/14/2010US20100260762 De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
10/14/2010US20100260760 Human anti-vegf polyclonal antibodies and uses thereof
10/14/2010US20100260756 Antibodies and related molecules that bind to 161p2f10b proteins
10/14/2010US20100260754 Dkk-1 antibodies
10/14/2010US20100260753 Aminoflavone (nsc 686288) and combinations thereof for treating breast cancer
10/14/2010US20100260751 Methods and Structural Conformations of Antibody Preparations with Increased Resistance to Proteases
10/14/2010US20100260748 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
10/14/2010US20100260738 Uses and methods relating to ndr kinase expression and/or activity
10/14/2010US20100260733 Novel anti aging agents and methods to identify them
10/14/2010US20100260719 Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
10/14/2010US20100260718 Irf-4 as a tumor suppressor and uses thereof
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010US20100260706 Compositions and methods for improving production of recombinant polypeptides
10/14/2010US20100260704 Human interferon-gamma (infgamma) variants
10/14/2010US20100260682 Compounds and methods of use thereof for assaying lysophospholipase D activity
10/14/2010US20100260678 Anti-igf-i receptor antibodies
10/14/2010US20100260674 Quinazoline derivatives and methods of treatment
10/14/2010US20100260673 Phage display peptide probes for imaging early responses to antiangiogenic treatment
10/14/2010US20100260669 Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010US20100260667 Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease
10/14/2010CA2758300A1 Checkpoint kinase 1 inhibitors for potentiating dna damaging agents
10/14/2010CA2758201A1 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
10/14/2010CA2758200A1 Nanoparticle formulations and uses thereof
10/14/2010CA2758071A1 Therapeutic compositions and related methods of use
10/14/2010CA2758019A1 Imidaz0[1,2-a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
10/14/2010CA2757941A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
10/14/2010CA2757912A1 Compounds that suppress cancer cells and exhibit antitumor activity
10/14/2010CA2757745A1 Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
10/14/2010CA2757744A1 Combination of decitabine with cytidine deaminase inhibitor and use thereof in the treatment of cancer
10/14/2010CA2757743A1 (2'-deoxy-ribofuranosyl)-1,3,4,7-tetrahydro-(1,3) diazepin-2-0ne derivatives for treating cancer
10/14/2010CA2757669A1 Bispecific anti-erbb-1/anti-c-met antibodies
10/14/2010CA2757368A1 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010CA2757138A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010CA2756568A1 Kinase inhibitors and method of treating cancer with same
10/14/2010CA2756246A1 Amatoxin-armed target-binding moieties for the treatment of cancer
10/14/2010CA2756245A1 Antibodies against human tweak and uses thereof
10/14/2010CA2756104A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
10/14/2010CA2755789A1 Treatment regimen utilizing neratinib for breast cancer
10/14/2010CA2753151A1 Substituted piperidines as ccr3 antagonists
10/14/2010CA2750836A1 Anti-siglec-15 antibody
10/13/2010EP2239581A1 Phosphorylation of histone H3 at threonine 11 - a novel epigenetic mark for transcriptional regulation
10/13/2010EP2239325A1 Virus growing in hypoxic cell or virus vector expressing gene therein
10/13/2010EP2239274A1 New methods for diagnosis and treatment of tumours
10/13/2010EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
10/13/2010EP2239264A1 Antitumor agent
10/13/2010EP2239262A2 Fused ring heterocycle kinase modulators
10/13/2010EP2239261A1 Pyrrolopyrimidin derivative for use as pi3k inhibitor, and use thereof
10/13/2010EP2238988A1 Conjugated prodrugs of cc-1065 analogs
10/13/2010EP2238984A1 Caspasin inhibitor peptides
10/13/2010EP2238982A2 Therapeutic agent for soft tissue sarcoma
10/13/2010EP2238973A1 Lyophilized preparations of proteasome inhibitors
10/13/2010EP2238251A1 Silencing of polo-like kinase expression using interfering rna
10/13/2010EP2238172A1 Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof
10/13/2010EP2238169A1 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates
10/13/2010EP2238168A1 Agents targeting cd138 and uses thereof
10/13/2010EP2238134A2 Bis-thiazole derivatives, process for their preparation and their use as medicaments
10/13/2010EP2238108A1 Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same
10/13/2010EP2238103A1 Novel n-(2-amino-phenyl)-amide derivatives
10/13/2010EP2237785A2 Triarylmethane analogs and their use in treating cancers
10/13/2010EP2237783A1 Method of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor kit with imatinib
10/13/2010EP2237780A1 Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives
10/13/2010EP1937667B1 Benzimidazoles useful as inhibitors of protein kinases
10/13/2010EP1877559B1 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
10/13/2010EP1781284B1 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1458734B1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer
10/13/2010EP1381631B1 Human anti timp-1 antibodies
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010EP1255553B1 Use of trilostane or keto-trilostane in combination with an antioestrogen in the treatment of a hormone-dependent condition.
10/13/2010EP1102848B1 Molecules designated ldcam
10/13/2010CN1953768B Highly concentrated liquid formulations of anti-EGFR antibodies
10/13/2010CN1946405B Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives
10/13/2010CN1919207B Gariic and medlar capsule
10/13/2010CN1896100B Liver regenerated factor and its use
10/13/2010CN1836683B Medicine for treating tumour and its preparing method
10/13/2010CN1754535B Paclitaxel analog microsphere for topical injection, its preparation method and uses
10/13/2010CN1646473B Novel curcumin analogues and uses thereof
10/13/2010CN1395581B Recombinant antibodies to human IL-1 beta
10/13/2010CN101861321A Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors
10/13/2010CN101861309A SALARIN and TULEARIN, compositions and uses thereof
10/13/2010CN101861307A Certain substituted amides, method of making, and method of use thereof
10/13/2010CN101861171A New compositions based on polysaccharides grafted by polyamine or polysulphurised compounds
10/13/2010CN101861164A Treatment of prion protein related diseases
10/13/2010CN101861162A Method for treating cancer via the mucosal administration of interleukin
10/13/2010CN101861161A Activin-ACTRIIA antagonists and uses for decreasing or inhibiting FSH secretion
10/13/2010CN101861159A Improved antitumoral treatments
10/13/2010CN101861151A Cancer combination therapy with a selective inhibitor of histone deacetylase HDAC1, HDAC2 and/or HDAC3 and a microtubule stabilizer
10/13/2010CN101857862A Let-7c gene fragment and miR-99+Let-7c coexpression gene fragment and application thereof
10/13/2010CN101857860A Application of viral nucleic acid sequence strictly conservative area as siRNA design template
10/13/2010CN101857618A Series of quinazoline sugar derivatives used as protein tyrosine kinase inhibitor, preparation method and application thereof
10/13/2010CN101857617A Quinazoline sugar derivative and preparation method and application thereof
10/13/2010CN101857610A Palladium complex and preparation method thereof
10/13/2010CN101857597A Diethylene triamine pentaacetic acid or ethylene diamine tetraacetic acid or amine triacetic acid modified porphyrin, preparation method and application thereof
1 ... 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 ... 2211